Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%
Phase 4
Completed
- Conditions
- Glaucoma
- Registration Number
- NCT00347802
- Lead Sponsor
- Innovative Medical
- Brief Summary
To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
-
· Male or female > 18 years of age
- Naive to treatment or washed off any ocular hypotensive agents
- Untreated IOP >19 mm Hg
- Diagnosis of open-angle glaucoma or ocular hypertension
- Ability to provide informed consent and likely to complete study
Exclusion Criteria
-
· Known contraindication to bimatoprost or travoprost, or any component of any study medication
- Uncontrolled systemic disease
- Active ocular disease other than glaucoma or ocular hypertension
- Required use of ocular medications other than the study medications during the study
- History of intraocular surgery within the last 3 months
- Prior discontinuation of any of the study medications for reasons related to efficacy or safety
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Dr. Noecker
🇺🇸Pittsburgh, Pennsylvania, United States